Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,448 total, page 16 of 29
Lamina Cribrosa Depth Change With Change in Eye Pressure
NCT03267849
Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis
NCT03450083
PREvention of VENous ThromboEmbolism Following Radical Prostatectomy
NCT03006562
Oral Sedation During Cervical Dilator Placement
NCT03202550
Vaginal Microbiota, and STI/HIV Risk Among Adolescent Girls and Young Women
NCT03196492
Financial Incentives to Reduce Pediatric Tobacco Smoke Exposures
NCT03099811
The IPV Provider Network: Engaging the Health Care Provider Response to Interpersonal Violence Against Women
NCT03259646
COach2Quit TRIAL: Assessing a Prototype Personal Carbon Monoxide Monitor for Smoking Cessation
NCT03142932
Vouchers to Increase Uptake of Already Free Eye Care
NCT04426331
Medication Adherence Research in COPD Patients
NCT03174704
Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain Stimulation
NCT03143894
Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)
NCT03100045
An EPIC Based BPA to Enhance Quit Line Referral and Use
NCT03229356
Impact of a Peer Support Program Amongst COPD Patients and Their Caregivers
NCT02891200
Procalcitonin for Stewardship in Respiratory Infections A Stewardship Project
NCT03109106
Trial of Orencia in Patients With Myasthenia Gravis
NCT03059888
Physical Activities by Technology Help (PATH)
NCT03212079
Assessment of Primary Oxygenation and Airflow Measurement for Endoscopic Laryngeal Surgery
NCT03222869
Ramelteon in the Prevention of Post-operative Delirium
NCT02324153
Behavioral Therapy for Tourette Syndrome
NCT03019731
Celecoxib for Thyroid Eye Disease
NCT02845336
Can we Train Patients With Chronic Stroke Out of Abnormal Hand Synergy?
NCT03255590
Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease
NCT02792257
Propranolol for Sleep Apnea Therapy
NCT03049306
The FIGHT-RP1 Study
NCT03063021
IPC for University Counseling Centers
NCT03255954
Improving Identification of Mental Health/Substance Use Disorders in HIV Primary Care: Pilot Clinical Response
NCT03067948
Transcutaneous Electroacupuncture for Gastric Complications of Scleroderma
NCT03294616
Muscle Derived Cell Therapy for Bladder Exstrophy Epispadias Induced Incontinence
NCT01011777
Notation Optimization Through Template Engineering
NCT04333238
Sugar Champ: Pilot Social Network Intervention to Reduce Intake of Sugary Drinks
NCT02138240
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
NCT02875704
Cognitive Behavior Therapy for Insomnia (CBT-I) in Persons With Traumatic Brain Injury (TBI)
NCT02709980
The Center for Peripartum Optimization
NCT03522909
Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.
NCT03027063
Comparison Between Wound Vacuum Dressing and Standard Closure to Reduce Rates of Surgical Site Infections
NCT03021668
Study of Tofacitinib in Refractory Dermatomyositis
NCT03002649
deLIVER: Direct Acting Antiviral Effects on the Liver
NCT02938013
Vitamin D to Improve Nutrition Prior to Bariatric Surgery and Investigate the Relationship With Negative Outcomes
NCT02212652
A Novel Biologic Therapy for Perennial Allergic Rhinitis
NCT03360071
Early Peanut Introduction: Translation to Clinical Practice
NCT03019328
Enhancing Medication-based Analgesia in Humans
NCT02901275
Sleep Disruption in Post-operative Patients in the Neurocritical Care Unit
NCT02997839
Rapid HIV Treatment Initiation, Access and Engagement in Care
NCT03512964
Personalized Smartphone-assisted Coaching System to Improve Glucose Homeostasis in Adults With Prediabetes
NCT02896010
Myocardial Infarction, COmbined-device, Recovery Enhancement Study
NCT03760796
Optimization of a Tenofovir Enema for HIV Prevention
NCT02750540
Improving Outcome for Family Caregivers of Older Adults With Complex Conditions: The Adult Day Plus (ADS Plus) Program
NCT02927821
Patient Engagement Initiative
NCT02721810
Cerebellar Transcranial Direct Current Stimulation and Aphasia Treatment
NCT02901574
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.